CERENIS THERAPEUTICS Quotes Cerenis Therapeutics LIQUIDNET SYSTEMS
Equities
FR0012616852
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.129 EUR | 0.00% |
|
0.00% | 0.00% |
| 14/03 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| 11/03 | Abionyx: reduced net loss in 2023 | CF |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
40 075 938
Capitalization (USD)
43 505 236
Net sales (EUR)
4 600 000
Net sales (USD)
4 993 622
Free-Float
68.01 %
Free-Float capitalization (EUR)
27 471 688
Free-Float capitalization (USD)
29 822 441
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 43.51M | ||
| -2.20% | +1.10% | +9.83% | +35.42% | 115B | ||
| -1.20% | -2.09% | +10.80% | +34.22% | 105B | ||
| -2.94% | +2.20% | -10.84% | -10.61% | 22.71B | ||
| +0.03% | -1.00% | -1.66% | -10.02% | 21.83B | ||
| -0.50% | -6.33% | -10.67% | -29.90% | 18.18B | ||
| -0.38% | -3.32% | -41.92% | -35.99% | 16.52B | ||
| +0.26% | -8.53% | -15.11% | -35.37% | 16.01B | ||
| +0.77% | -0.05% | +6.62% | +54.00% | 14.14B | ||
| -8.21% | -12.23% | +17.53% | -10.64% | 10.71B | ||
| +0.65% | -2.98% | -30.73% | -33.98% | 7.6B | ||
| -0.80% | -1.84% | -3.30% | +22.75% | 7.47B | ||
| -0.09% | -6.72% | +9.39% | +40.29% | 7.47B | ||
| -2.36% | +3.65% | +1.10% | +41.87% | 7.3B | ||
| +4.16% | +1.76% | +251.21% | +206.71% | 7.21B | ||
| -2.73% | -13.22% | -61.42% | -72.81% | 6.25B | ||
| Average | -0.97% | -2.79% | +8.72% | +13.06% | ||
| Weighted average by Cap. | -1.41% | -1.32% | +6.21% | +20.11% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
- Stock Market
- Equities
- ABNX Stock
- Stock
- Quotes Cerenis Therapeutics
